Brokerages Set WELL Health Technologies Corp. (TSE:WELL) Target Price at C$7.35

WELL Health Technologies Corp. (TSE:WELL) has been given an average rating of “Buy” by the six brokerages that are covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is C$7.35.

A number of research firms have recently commented on WELL. Scotiabank dropped their target price on shares of WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating for the company in a report on Wednesday, February 4th. Canadian Imperial Bank of Commerce raised shares of WELL Health Technologies from a “neutral” rating to an “outperform” rating in a research note on Wednesday, December 3rd.

WELL Health Technologies Price Performance

Shares of WELL stock opened at C$3.96 on Wednesday. The business has a fifty day simple moving average of C$4.04 and a 200 day simple moving average of C$4.49. The company has a market cap of C$1.01 billion, a P/E ratio of -44.00, a P/E/G ratio of -1.93 and a beta of 0.49. The company has a quick ratio of 1.02, a current ratio of 1.14 and a debt-to-equity ratio of 46.79. WELL Health Technologies has a twelve month low of C$3.58 and a twelve month high of C$6.35.

About WELL Health Technologies

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.